Belgium· BE-AMP-SAM554142-00
Aklief 50 µg/g
A medicinal product containing trifarotene, registered in Belgium by Galderma Benelux.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Trifarotene
- Manufacturer
- Galderma Benelux
- Country
- Belgium (BE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trifarotene in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAKLIEFGalderma International, La Défense
- PolandAkliefGalderma Polska Sp. z o.o.
- SwitzerlandAklief
- GermanySelgamisGalderma Laboratorium Gmbh
- SpainAKLIEF 50 MICROGRAMOS/G CREMALaboratorios Galderma S.A.
- FinlandAkliefGalderma Nordic AB
- FranceAKLIEF 50 microgrammes/g, crèmeGALDERMA INTERNATIONAL
- United KingdomAklief 50micrograms/g creamGalderma (UK) Ltd
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Bulgaria · Аклиеф
- Cyprus · Selgamis
- Czechia · Aklief
- Germany · Selgamis
- Denmark · Aklief
- Estonia · Aklief
- Spain · Aklief
- Finland · Aklief
- France · Aklief
- United Kingdom (Northern Ireland) · Aklief
- Greece · Selgamis
- Croatia · Aklief
- Hungary · Aklief
- Ireland · Aklief
- Iceland · Aklief
- Italy · Selgamis
- Lithuania · Aklief
- Luxembourg · Aklief
- Latvia · Aklief
- Malta · Aklief
- Netherlands · Aklief
- Norway · Aklief
- Poland · Aklief
- Portugal · Aklief
- Romania · Aklief
- Sweden · Aklief
- Slovakia · Aklief
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8a758cb8-047b-4c93-95a1-9db609b519eb GET /v1/drugs/8a758cb8-047b-4c93-95a1-9db609b519eb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Cream",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Aklief 50 µg/g",
"name_fr": "Aklief 50 µg/g",
"name_nl": "Aklief 50 µg/g",
"amp_code": "SAM554142-00",
"strengths": [
"0.0500"
],
"pack_count": 0,
"substances": [
"Trifarotene"
],
"medicine_type": "ALLOPATHIC",
"atc_description": null,
"authorisation_numbers": null
}See everything about trifarotene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.